Sequre Dx

Developer of personalized diagnostics for gene-editing therapies

placeWaltham, Massachusetts, United States calendar_todayFounded 2020 groups29 employees language sequre-dx.com

Innovation

2 patent families — focus: Chemistry & metallurgy; filing pace active. Cited 10 times.

YearFilings
20241
20252

Social engagement

Social engagement: 2K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include RiverVest Venture Partners, Mass General Brigham Ventures.

Investor typeCountShare
Venture capital686%
Other / undisclosed114%
Coming soon